VIEWPOINTS PharmaShots Interview: Seattle Children’s Research Institute’ Fred David Mast Shares Insight on Nanobodies for the Prevention of COVID-19BySenior EditorMarch 31, 20220Comments
EXCLUSIVE Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Shares Insight on Neural Sleeve for Neurological DisordersBySenior EditorMarch 30, 20220Comments
VIEWPOINTS PharmaShots Interview: Eli Lilly’s Eric Pearlman Shares Insight on Emgality (galcanezumab-gnlm) for the Treatment of Episodic MigraineBySenior EditorMarch 29, 20220Comments
INSIGHTS+ Insights+: Trends in the US FDA Oncology Approvals (2011-2021)BySenior EditorMarch 24, 20220Comments
VIEWPOINTS PharmaShots Interview: Takeda’s Elke Walter & Derek Wallace Share Insights on TAK-003 for Dengue & Zika VirusesBySenior EditorMarch 23, 20220Comments
VIEWPOINTS PharmaShots Interview: Astellas’ John C. Hairston & Gabriel P. Haas Share Insights on Xtandi (enzalutamide) for the Treatment of Prostate CancerBySenior EditorMarch 22, 20220Comments
VIEWPOINTS PharmaShots Interview: Tillotts Pharma’s Adrian Hill & Christian Weidenfeller Share Insights on Dificlir (fidaxomicin) for the Treatment of Clostridioides Difficile InfectionBySenior EditorMarch 21, 20220Comments
